SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PHP Healthcare
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Mac who wrote (59)7/14/1998 10:10:00 AM
From: DENNIS DOCKERY  Read Replies (2) of 136
 
John Kluge has purchased up to his limit of 15%. If PHP can achieve a
75% to 79% loss ratio, $50 to $70 reduction from HIP historical number, new enrollments in July, 5% to 8% rate increases. This company should have significate earnings and cash flow to report. I hope management is not too optimistic. Cash flow would increase for more buy backs if DC repayment is made.

The analyst are conservative in their reporting. The only thing keeping this stock down is the uncertainty of the convertible preferred stock. The short interest has won so far but things will turn and I hope they get squeezed against the wall. This company should have a stock cap around $400 to $500 million.

This negative sector should soon turnaround. A recent strong buy was made on Phycor (PHYC). This company has similar earnings forecast but their stock price is around the high 16's.

I hope we win and the shorts lose soon.

Still scooping

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News